EDN1 and endothelial dysfunction: As expected, administering tumor necrosis factor α (TNF-α) caused a potent increase in vascular cell adhesion molecule 1 (VCAM-1, Fig 3A; see S2 File) and Endothelin-1 (ET-1, Fig 3B; see S2 File), markers of endothelial dysfunction.